This proposal focuses on how mammals can mitigate the damage resulting from the inevitable accumulation of covalently altered proteins within cells. Two of the major sites of spontaneous covalent damage in proteins are aspartic acid and asparagine residues, where isomerization, racemization, and deamidation reactions can affect protein function as well as the ability of the protein to interact normally with other proteins. Evidence has been presented that cells can limit this damaged by utilizing a repair pathway driven by the intracellular enzyme, L- isoaspartate (D-aspartate) O-methyltransferase, or protein carboxyl methyltransferase(pcmt). Pcmt recognized damaged proteins containing isomerized and racemized aspartyl residues and initiates the conversion of those residues to normal L-aspartyl residues. We have been interested in asking how pcmt prevents the build-up of senescent and potentially toxic proteins, which otherwise might lead to a loss of cellular function in the aging process. To study this issue, we have generated pcmt-deficient mice. The cytosolic proteins of the knockout mice accumulate high levels of D- aspartyl and L-isopartyl residues. The most remarkable phenotypes of the knockout mice are retard growth and a seizure disorder, which results in death at an average of 42 days of age. We now propose to use the knockout mice and their cells and tissue to answer a number of questions that related to the effect of damaged proteins on the aging process. We will use a cell culture system the examine the hypothesis that the accumulation of proteins containing altered aspartyl residues causes cellular dysfunction and results in diminished cell survival. Because homozygous knockout mice die early from seizures, they cannot be used to assess long-term effect of the protein methyltransferase deficiency in various tissues. Thus, we propose to do bone-marrow transplantation experiments to determine if activation of the methyltransferase gene in hematopoietic or immune cells causes age- dependent cellular dysfunction. We will also rescue the knockout mice from the seizure disorder with a human pcmt transgene under the control of a neuron-specific promoter. Using the rescued mice, we will be able to determine if the absence of methyltransferase activity in non-neuronal tissues (such as the heart or liver) results in age-dependent pathology or cellular dysfunction. Finally, we propose to ask whether the expression of the repair methyltransferase in the extracellular compartment would limit the accumulation of spontaneous damage to extracellular proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG015451-04
Application #
6372193
Study Section
Biochemistry Study Section (BIO)
Program Officer
Bellino, Francis
Project Start
1998-07-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
4
Fiscal Year
2001
Total Cost
$315,165
Indirect Cost
Name
J. David Gladstone Institutes
Department
Type
DUNS #
047120084
City
San Francisco
State
CA
Country
United States
Zip Code
94158
Maske, Christopher P; Hollinshead, Michael S; Higbee, Niall C et al. (2003) A carboxyl-terminal interaction of lamin B1 is dependent on the CAAX endoprotease Rce1 and carboxymethylation. J Cell Biol 162:1223-32
Winter-Vann, Ann M; Kamen, Barton A; Bergo, Martin O et al. (2003) Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate. Proc Natl Acad Sci U S A 100:6529-34
Farrar, Christine; Clarke, Steven (2002) Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of L-isoaspartyl (D-Aspartyl) O-methyltransferase-deficient mice. J Biol Chem 277:27856-63
Bergo, Martin O; Ambroziak, Patricia; Gregory, Cria et al. (2002) Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Mol Cell Biol 22:171-81
Bergo, Martin O; Gavino, Bryant; Ross, Jed et al. (2002) Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A 99:13049-54
Beigneux, Anne; Withycombe, Shannon K; Digits, Jennifer A et al. (2002) Prenylcysteine lyase deficiency in mice results in the accumulation of farnesylcysteine and geranylgeranylcysteine in brain and liver. J Biol Chem 277:38358-63
Bergo, M O; Leung, G K; Ambroziak, P et al. (2001) Isoprenylcysteine carboxyl methyltransferase deficiency in mice. J Biol Chem 276:5841-5
Lowenson, J D; Kim, E; Young, S G et al. (2001) Limited accumulation of damaged proteins in l-isoaspartyl (D-aspartyl) O-methyltransferase-deficient mice. J Biol Chem 276:20695-702
Leung, G K; Schmidt, W K; Bergo, M O et al. (2001) Biochemical studies of Zmpste24-deficient mice. J Biol Chem 276:29051-8
Bergo, M O; Leung, G K; Ambroziak, P et al. (2000) Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells. J Biol Chem 275:17605-10

Showing the most recent 10 out of 14 publications